TY - JOUR
T1 - Informed consent
T2 - A clinical trials perspective
AU - Hammer, Marilyn J.
AU - Eckardt, Patricia
AU - Barton-Burke, Margaret
N1 - Publisher Copyright:
Copyright 2016 by the Oncology Nursing Society.
PY - 2016/11
Y1 - 2016/11
N2 - The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored.
AB - The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored.
KW - Biology of cancer
KW - Ethics
KW - Genetics
KW - Nursing research
UR - http://www.scopus.com/inward/record.url?scp=84992195289&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992195289&partnerID=8YFLogxK
U2 - 10.1188/16.ONF.694-696
DO - 10.1188/16.ONF.694-696
M3 - Article
C2 - 27768140
AN - SCOPUS:84992195289
SN - 0190-535X
VL - 43
SP - 694
EP - 696
JO - Oncology nursing forum
JF - Oncology nursing forum
IS - 6
ER -